inhibitors - inhibitors Manufacturer Supplier Exporter

Price

Supplier Type

Manufacturer
Trader
Reagent
contract manufacturer
custom synthesis

Supplier Region

Hyderabad(9)
Gujarat(16)
Mumbai(18)
Telangana(2)
Maharashtra(19)
Bangalore(1)
Ahmedabad(5)
Nagpur(1)
Haryana(2)
Delhi(2)
Uttar Pradesh(3)
Vadodara(1)
Pune(1)
Tamil Nadu(2)
Karnataka(2)
Beijing(1)
New Delhi(2)
Andhra Pradesh(2)

Purity

Z-VAD-FMK, CAS 187389-52-2, is a cell-permeable, irreversible, pan-caspase inhibitor.
VETRANAL?, analytical standard
United States Pharmacopeia (USP) Reference Standard
synthetic, ≥90% (HPLC)
solid, ≥98% (HPLC)
solid
Single-chain glycoprotein present in normal serum at about 23 mg/100 ml.
reference standard
recombinant
puriss. p.a., absolute, ≥99.5% (GC)
powder, ≥98% (HPLC)
powder
Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM).
pharmaceutical secondary standard, certified reference material
Pharmaceutical Secondary Standard
NLT 95%
Min. 99%
lyophilized powder, ≥95% (SDS-PAGE)
LRRK2-IN-1 primarily used in Inhibition.
ISOPAC?
InSolution,≥95%
InSolution, ≥98%, 50 mM in DMSO, A cell-permeable benzodiazepine compound
InSolution, ≥98%, 5 mg/ml, reversible inhibitor of MAP Kinase Kinase (MEK)
InSolution, ≥98%, 25 mM in DMSO
InSolution, ≥98%, 10 mM, reversible proteasome inhibitor
InSolution, ≥98%, 10 mM, reversible and specific inhibitor of PI 3-kinase
InSolution, ≥98%, 1 mg/ml, reversible inhibitor of p38 MAP kinase
InSolution, ≥97%, 25 mM in DMSO
InSolution, ≥97%
InSolution, ≥95%, protein kinase C (PKC) inhibitor
InSolution, ≥95%, Inhibitor of protein kinase C
InSolution, ≥95%, inhibitor of cyclin-dependent kinases (CDKs)
InSolution, ≥95%
Hesperadin primarily used in Inhibition.
HCl 98%
Greater than 99%
European Pharmacopoeia (EP) Reference Standard
CRS, European Pharmacopoeia (EP) Reference Standard
Certified Reference Material
bulk package
British Pharmacopoeia (BP) Reference Standard
BioReagent, suitable for fluorescence, ≥96.0% (HPLC)
Batimastat primarily used in Inhibition.
analytical standard
AldrichCPR
A widely used anti-neoplastic agent that also displays immunosuppressant properties.
A potent, cell-permeable, reversible, and selective inhibitor of cyclin-dependent kinases.
A potent inhibitor of HDACs and receptor tyrosine kinases
A natural metabolite of 17β-estradiol that is devoid of estrogenic activity.
A cell-permeable, potent, reversible proteasome inhibitor (Ki = 4 nM).
A cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality.
99.94%
99.9%
99.66%
99.5%
≥99.5%
99.10%
≥99.0% (NT)
99%+
99% purity
99%
98+
98.50%
98.42%
98.32%
98.0-102.0%, solid
98.00%
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(N)
>98.0%(HPLC)(N)
>98.0%(HPLC)
>98.0%(GC)
≥98% (TLC)
≥98% (HPLC), white to off-white, powder
>98% (HPLC), solid
≥98% (HPLC), solid
≥98% (HPLC), powder
≥98% (HPLC)
>98% (HPLC)
98%
98 %
97-99%
>97.0%(N)
>97.0%(HPLC)(N)
>97.0%(HPLC)
>97.0%(GC)
≥97% (HPLC), solid
≥97% (HPLC)
97%
95.00%
>95.0%(T)(HPLC)
>95.0%(HPLC)
≥95%, solid
≥95% (HPLC), powder
>95% (HPLC)
≥95% (HPLC)
90070559
>90.0%(HPLC)
≥90% (HPLC)
90 % Above
100%
1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
&ge